TriOSS® is a beta-Tricalcium Phosphate bone graft with optimized porosity to promote vascularization and rapid bone integration.
TriOSS® is a fully synthetic bone graft material composed of β-Tricalcium Phosphate (β-TCP), specifically developed for the filling of bone defects. Its chemical composition closely resembles the mineral phase of human bone, ensuring excellent biocompatibility and osteoconductivity.
Thanks to its highly porous structure, TriOSS® enables complete vascularization and cellular infiltration, promoting efficient integration and bone regeneration. The material is gradually resorbed and replaced by newly formed bone during the healing process.
TriOSS® is presented in multiple shapes—including blocks, wedges, cylinders, and granules—to suit a wide range of surgical applications.
Case of a 32-year-old male with tooth 46 inflammation, treated with Trioss® and Healvisco® after extraction. Full integration with no adverse events.
Case of a 35-year-old male with a malignant shoulder tumor, treated with debridement and antibiotic spacer in Stage 1, followed by bone grafting and stabilization in Stage 2.
N-IBS® is a premium injectable bone substitute composed of hydroxyapatite in an aqueous solution. It facilitates vascular and cellular invasion, promoting natural bone growth without providing structural support.
Neobone® is a calcium phosphate bone substitute that mimics natural bone structure, combining tricalcium phosphate and hydroxyapatite. Its porosity supports complete vascularization, enabling long-term regeneration.
As medical technologies advance, innovative products like this transform patient care, enabling precise interventions, improved outcomes, and faster recovery.
Neocement® is a calcium phosphate cement offering strong in situ hardening for orthopedic and trauma surgeries. Moldable for precise defect filling.
Neocement® Inject P is an injectable calcium phosphate bone cement designed for in situ hardening. Promotes vascularization and bone regeneration.